A Microsoft-led research team has demonstrated that generative AI protein design platforms can modify toxic proteins to evade current DNA synthesis screening software while maintaining functionality. This proof-of-concept highlights significant biosecurity vulnerabilities as AI-driven molecular engineering matures, enabling creation of novel designer proteins including potential bioweapons. The team advocates for continuous testing and collaborative patching of biosecurity safeguards to mitigate emerging threats from adversarial AI applications in biotechnology.